These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17924666)

  • 41. Conservation of the pyrrolnitrin biosynthetic gene cluster among six pyrrolnitrin-producing strains.
    Hammer PE; Burd W; Hill DS; Ligon JM; van Pée K
    FEMS Microbiol Lett; 1999 Nov; 180(1):39-44. PubMed ID: 10547442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histidine 55 of tryptophan 2,3-dioxygenase is not an active site base but regulates catalysis by controlling substrate binding.
    Thackray SJ; Bruckmann C; Anderson JL; Campbell LP; Xiao R; Zhao L; Mowat CG; Forouhar F; Tong L; Chapman SK
    Biochemistry; 2008 Oct; 47(40):10677-84. PubMed ID: 18783250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of nitric oxide to reduced L-tryptophan-2,3-dioxygenase as studied by electron paramagnetic resonance.
    Henry Y; Ishimura Y; Peisach J
    J Biol Chem; 1976 Mar; 251(6):1578-81. PubMed ID: 176157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
    Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How is the distal pocket of a heme protein optimized for binding of tryptophan?
    Chauhan N; Basran J; Rafice SA; Efimov I; Millett ES; Mowat CG; Moody PC; Handa S; Raven EL
    FEBS J; 2012 Dec; 279(24):4501-9. PubMed ID: 23083473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis.
    Papadopoulou ND; Mewies M; McLean KJ; Seward HE; Svistunenko DA; Munro AW; Raven EL
    Biochemistry; 2005 Nov; 44(43):14318-28. PubMed ID: 16245948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias.
    Badawy AA
    Med Hypotheses; 2019 Oct; 131():109314. PubMed ID: 31443750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase?
    Ren S; Correia MA
    Arch Biochem Biophys; 2000 May; 377(1):195-203. PubMed ID: 10775460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular evolution of bacterial indoleamine 2,3-dioxygenase.
    Yuasa HJ; Ushigoe A; Ball HJ
    Gene; 2011 Oct; 485(1):22-31. PubMed ID: 21689736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
    Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
    Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The heme environment of recombinant human indoleamine 2,3-dioxygenase. Structural properties and substrate-ligand interactions.
    Terentis AC; Thomas SR; Takikawa O; Littlejohn TK; Truscott RJ; Armstrong RS; Yeh SR; Stocker R
    J Biol Chem; 2002 May; 277(18):15788-94. PubMed ID: 11867636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).
    Macchiarulo A; Nuti R; Bellocchi D; Camaioni E; Pellicciari R
    Biochim Biophys Acta; 2007 Aug; 1774(8):1058-68. PubMed ID: 17644054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the prosthetic groups of L-tryptophan 2,3-dioxygenase from Pseudomonas: evidence for noninvolvement of copper in the reaction.
    Ishimura Y; Hayaishi O
    Adv Exp Med Biol; 1976; 74():363-73. PubMed ID: 183474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive comparison of the metazoan tryptophan degrading enzymes.
    Yuasa HJ
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140247. PubMed ID: 31276825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanistic Insights into the Oxidative Rearrangement Catalyzed by the Unprecedented Dioxygenase ChaP Involved in Chartreusin Biosynthesis.
    Li X; Zhu W; Liu Y
    Inorg Chem; 2020 Oct; 59(19):13988-13999. PubMed ID: 32951427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase.
    Batabyal D; Yeh SR
    J Am Chem Soc; 2007 Dec; 129(50):15690-701. PubMed ID: 18027945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tryptophan-catabolizing enzymes - party of three.
    Ball HJ; Jusof FF; Bakmiwewa SM; Hunt NH; Yuasa HJ
    Front Immunol; 2014; 5():485. PubMed ID: 25346733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The biosynthesis of the antibiotic pyrrolnitrin by Pseudomonas aureofaciens.
    Chang CJ; Floss HG; Hook DJ; Mabe JA; Manni PE; Martin LL; Schröder K; Shieh TL
    J Antibiot (Tokyo); 1981 May; 34(5):555-66. PubMed ID: 7275838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biosynthesis of pyrrolnitrin. Incorporation of 13C, 15N double-labelled D- and L-tryptophan.
    Zhou P; Mocek U; Siesel B; Floss HG
    J Basic Microbiol; 1992; 32(3):209-14. PubMed ID: 1512712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of Drosophila melanogaster tryptophan 2,3-dioxygenase reveals insights into substrate recognition and catalytic mechanism.
    Huang W; Gong Z; Li J; Ding J
    J Struct Biol; 2013 Mar; 181(3):291-9. PubMed ID: 23333332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.